Search

everythinglearnresearchcommunity

for

Search:↓

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

The scalp has a natural speckled pattern of increased pigment around hair follicles, possibly linked to local hormone production.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Women also use 5α-reductase inhibitors, and their effects differ from men.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Accidental findings have led to new hair treatment discoveries, like using blood pressure and diabetes medications for hair loss and unwanted hair.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

Cosmeceuticals may benefit skin health but need more research for efficacy and safety confirmation.

Homeopathy can effectively treat pattern hair loss by using remedies like Lycopodium Clavatum and Natrum Muriaticum, tailored to the patient's overall condition.

The document concluded that home treatments are needed for hair loss control, but professionals should better understand how these treatments work.

Minoxidil and finasteride effectively treat hair loss.

Male pattern baldness involves three mechanisms and finasteride can help reverse it.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.